No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1206-1210

  Skjærbæk, Christian ^a,b   Kaal, Andreas ^a   Møller, Jens ^b   Vahl, Nina ^b   Weeke, Jørgen ^b   Ørskov, Hans ^a   Flyvbjerg, Allan ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION;

ACROMEGALY; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROLYSIS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED;

EID: 0031791034     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1206     Document Type: Article

References (30)

1. Shimasaki S, Shimonaka M, Zhang HP, Ling N. 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rats serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 266:10646-10653.
2. Shimasaki S, Gao L, Shimonaka M, Ling N. 1991 Isolation and molecular cloning of IGFBP-6. Mol Endocrinol. 5:938-948.
3. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. 1996 Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7. Recombinant human mac25 specifically binds 1GF-I and -II. J Biol Chem. 271:30322-20325.
4. Jones JI, Clemmons DR. 1995 Insulin-like growth factors, and their binding proteins: biological actions. Endocr Rev. 16:3-34.
5. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150-K complex during pregnancy. J Clin Endocrinol Metab. 71:797-805.
6. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation, and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
7. Cotterill AM, Holly JM, Taylor AM, et al. 1992 The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. J Clin Endocrinol Metab. 74:56-63.
8. Timmins AC, Cotteril AW, Cwyfan Hughes SC, et al. 1996 Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med. 24:1460-1466.
9. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. 1995 Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab. 80:2282-2288.
10. Bang P, Brismar K, Rosenfeld RG. 1994 Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130-to 150-kDa ternary complex. J Clin Endocrinol Metab. 78:1119-1127.
11. Cwyfan-Hughes SC, Cotterill AM, Molloy AR, et al. 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol. 135:135-145.
12. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG. 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology. 131:3051-3060.
13. Lalou C, Binoux M. 1993 Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream. Regul Pept. 48:179-188.
14. Lassarre C, Binoux M. 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology. 134:1254-1262.
15. Binoux M, Lalou C, Lassarre C, Blat C, Hossenlopp P. 1994 Limited proteolysis of insulin-like growth factor binding protein-3 (ICFBP-3); a physiological mechanism in the regulation of IGF bioavailability. In: LeRoith D, Raizada MK, eds. Current directions in insulin-like growth factor research. New York: Plenum Press; 293-300.
16. Blat C, Villaudy J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2286-2290.
17. Lassarre C, Lalou C, Perin L, Binoux M. 1994 Protease-induced alteration of insulin-like growth factor binding protein-3 as detected by radioimmunoassay. Agreement with ligand blotting data. Growth Regul. 4:48-55.
18. Rutishauser J, Schmid C, Hauri C, Froesch ER, Zapf J. 1993 Growth hormone, but not insulin-like growth factor 1, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett. 334:23-26.
19. Fielder PJ, Thordarson G, Talamantes F, Rosenfeld RG. 1990 Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity. Endocrinology. 127:2270-2280.
20. Lamson G, Giudice LC, Rosenfeld RG. 1991 A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab. 72:1391-1393.
21. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
22. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W. 1992 Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia. 35:589-593.
23. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P. 1996 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology. 137:2676-2682.
24. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1046-1053.
25. Lalou C, Silve C, Rosato R, Segovia B, Binoux M. 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology. 135:2318-2326.
26. Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP. 1995 Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels in and IGFBP-3 protease activity in normal, abnormal and multiple human pregnancy. J Clin Endocrinol Metab. 80:21-27.
27. Laron Z, Kowadlo-Silbergeld A, Eshet R, Pertzelan A. 1980 Growth hormone resistance. Ann Clin Res. 12:269-277.
28. Geffner ME, Golde DW, Lippe BM, Kaplan SA, Bersch N, Li CH. 1987 Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone. J Clin Endocrinol Metab. 64:1042-1046.
29. Fielder PJ, Guevara-Aguirre J, Rosenbloom AL, Carlsson L, Hintz RL, Rosenfeld RG. 1992 Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients. J Clin Endocrinol Metab. 74:743-750.
30. Vaccarello MA, Diamond FBJ, Guevara-Aguirre J, et al. 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 77:273-280.